Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5656650 | ABBVIE | Angiotensin II receptor blocking compositions |
Aug, 2014
(9 years ago) |
Market Authorisation Date: 22 December, 1997
Treatment: Treatment of hypertension
Dosage: TABLET;ORAL